0002029039 2026-05-26 2026-05-26 0002029039 1 2026-05-26 2026-05-26 iso4217:USD pure shares S-8 S-8 EX-FILING FEES 0002029039 Nasus Pharma Ltd N/A false S-8 Nasus Pharma Ltd Equity Ordinary Shares, no par value per share true 1023178 2.82 2885361.96 0.0001381 398.47 2885361.96 398.47 0.00 398.47 Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement also covers an indeterminate number of additional securities which may be offered and issued to prevent dilution resulting from share splits, share dividends, recapitalizations or similar transactions. The amount registered represents ordinary shares, no par value per share ("Ordinary Shares"), of the Registrant reserved for issuance upon the exercise of securities that may be granted under the plan to which this Registration Statement relates. The proposed maximum offering price per share is based on the number of Ordinary Shares which may be issued under the Registrant's 2019 Incentive Option Plan that this Registration Statement on Form S-8 relates to and is estimated in accordance with Rule 457(c) and (h) under the Securities Act solely for the purpose of calculating the registration fee based upon the average of the high and low sales price of the Ordinary Shares as reported on the NYSE American LLC on May 20, 2026.